Skip to content

Comparison of patient-controlled administration of hydromorphone andsufentanil in patients after colorectal surgery

Comparison of patient-controlled administration of hydromorphone andsufentanil in patients after colorectal surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007112
Enrollment
Unknown
Registered
2015-09-20
Start date
2015-09-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

undergoing Colorectal sugery

Interventions

Group A(Hydromorphone) :receive PCA-administered Hydromorphone postoperatively
Group B(Sufentanil) :receive PCA-administered Sufentanil postoperatively

Sponsors

First Affiliated Hospital, College of Medicine, Zhejiang University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. To be aged between 18-80 years old; 2. Male or female; 3. Body mass index between normal scale+/-20%; 4. ASA I-II; 5. Scheduled for elective,laparoscopic or open surgery for colorectal sugery; 6. Be voluntary to participate the research sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Have a history of mental illness, long-term history of chronic pain take the town for a long time, painkillers, sedatives, anti depression drugs, anti anxiety drug history, NSAIDs drugs, alcohol drug abuse history; 2. Hepatic renal function seriously abnormal; 3. Have a history of abnormal operation or anesthesia; 4. Have a history of gastroesophageal reflux; 5. Those who had received sedatives, antemetic or anticnesmatic within the previous 24 hours; 6. Allergic to opioid; 7. Those who had received MAOI or anti depression drugs within the previous 15 days; 8. Unable to understandVAS score, Digit, Trail Making, unable to use PCA; 9. The patients sended to ICU after operation; 10. Pregnant or lactate; 11. Those who have anxiety or depression.

Design outcomes

Primary

MeasureTime frame
Median VAS pain scores coughing at rest;PHS score;Mood-POMS evaluate;Cognitive Function Measures;

Secondary

MeasureTime frame
satisfaction;anal exsufflation time;post-operative hospital stay;the time to wal;

Countries

China

Contacts

Public ContactZhiying Feng
13989881666@163.com+86 13989881666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 7, 2026